InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,487.03
(
0.25%
)
US TECH 100
19,426.40
(
0.12%
)
Dow Jones
38,834.86
(
0.15%
)
Brent Oil
84.79
(
0.00%
)
Bitcoin
65,425.84
(
0.43%
)
Post# of 252254
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

biomaven0

Send PM Follow Ignore
Followers 82
Posts 4778
Boards Moderated 0
Alias Born 02/27/2007

biomaven0

Re: tinkershaw post# 113303

Tuesday, 01/25/2011 11:54:31 PM

Tuesday, January 25, 2011 11:54:31 PM

Post# of 252254

Teva's version of generic Lovenox, which is manufactured and tested outside of the U.S." That defense disappears as soon as Teva attempts to market in the U.S. (which is the entire basis for the ANDA to begin with).



What if their research and tweaking of the process to manufacture the molecule made use of techniques that overlap MNTA's patent, but the end manufacturing process (including quality control) uses techniques that do not infringe? That would be my guess for one of their defenses.

Peter



Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up